AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Patient Journey Analysis Helped an Angiogenesis Inhibitors Manufacturer to Improve Drug Performance by 2x | Read Quantzig’s Success Story for Detailed Insights

November 5, 2019

LONDON--(BUSINESS WIRE)--Nov 5, 2019--

Quantzig, a global data analytics and advisory firm that delivers actionable analytics solutions to resolve complex business problems, has announced the completion of its latest success story that explains ’ How Patient Journey Analysis Helps Improve Drug Performance.’

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191105005069/en/

This success story highlights the role of patient journey analysis in identifying the most effective drugs and treatment patterns based on a detailed analysis of patient journeys. Also, it explains how Quantzig’s analytics experts helped a leading manufacturer of angiogenesis inhibitors to understand the effectiveness of clinical trials against real-world data.

Our patient journey analytics solutions help healthcare providers to gain adequate insights on optimizing performance across patient access, coding and documentation, and reimbursement. Request a FREE proposal to learn more about our analytics capabilities.

Today, healthcare service providers have been forced to comply with the regulatory guidelines set forth by governments across the globe. Additionally, with the fluctuating changes in regulatory requirements, it becomes necessary for manufacturers of angiogenesis inhibitors to stay relevant and keep-up-to-date with the regulatory changes and ensure that they meet all the mandates.

According to Quantzig’s real-world evidence analytics experts,“Patient journey analysis can serve as the platform to unite stakeholders across the health care ecosystem to achieve one overarching goal i.e., the affordable management of healthcare, both individually and across the population.”

Talk to our analytics expertsto learn how we can help you develop impactful pharma marketing and communications strategies by adopting a holistic approach to patient journey analysis.

The Challenge

The client wanted to validate the efficacy of their clinical trials by understanding the ailment progression in patients under the influence of several therapies in the real-world setting. Also, the client further wanted to understand the drug performance in the real world when compared to the ideal settings with the help of real-world data.

Our Approach

Quantzig’s team of 20+ real-world evidence analytics experts worked parallel with the client to help them understand the effectiveness of clinical trials against real-world data based on the insights and findings from the patient journey. Additionally, the client gained valuable insights into the drug’s performance in the real world when compared to the ideal settings.

Assessing the touchpoints to improve patient care is a challenging task for healthcare businesses. Don’t you agree? Book a FREE solution demo to learn how our patient journey analytics solutions can help you address such challenges efficiently and improve business outcomes.

Quantzig’s patient journey analysis also enabled the client to:

Recent Success Stories:

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal

View source version on businesswire.com:https://www.businesswire.com/news/home/20191105005069/en/

CONTACT: Quantzig

Anirban Choudhury

Marketing Manager

US: +1 630 538 7144

UK: +44 208 629 1455

https://www.quantzig.com/contact-us

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Quantzig

Copyright Business Wire 2019.

PUB: 11/05/2019 09:30 AM/DISC: 11/05/2019 09:30 AM

http://www.businesswire.com/news/home/20191105005069/en